Chongqing University Cancer Hospital

This study is for people with a specific, high-risk type of nasopharyngeal cancer. All participants get the standard treatment of chemotherapy and radiation together. For those whose blood tests still show signs of the cancer virus during treatment, the study tests if adding a lo…

This study is testing whether adding a drug called tislelizumab to standard chemotherapy, followed by a personalized radiation plan, can better control advanced nasopharyngeal cancer that has already spread. It enrolled 32 adults whose tumors shrank after initial chemo-immunother…